Glimpse Group VRAR 深 沪
已收盘 08-01 16:00:00 美东时间
1.405
-0.085
-5.70%
华盛通- 最 高1.47
- 今 开1.44
- 成交量 31.67万股
- 最 低 1.34
- 昨 收 1.49
- 总市值 2958.30万
- 52周最高 7.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.5032
- 委 比 79.98%
- 总股本 2105.55万
- 历史最高 21.00
- 量 比 1.38
- 振 幅 8.72%
- 历史最低 0.5032
- 每 手 1
- 风险率 0.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多The Glimpse Group Expects Preliminary Q4 Revenue Of $3.5M, Up By ~100% YoY, Positive Quarterly Adj EBITDA, Cash Balance Of $6.85M
The Glimpse Group, Inc. ("Glimpse") (NASDAQ:VRAR, FSE: 9DR))), a diversified Immersive Technology platform company providing enterprise-focused Virtual Reality ("VR"), Augmented Reality ("AR") and Spatial Computing
07-15 17:21
The Glimpse Group Provides Preliminary Unaudited Q4 Fiscal Year ’25 Results: 100% Organic Revenue Growth ($3.5MM) And Positive EBITDA
Glimpse Group reported a 100% increase in Q4 FY'25 revenues to $3.50 million, up from $1.73 million in Q4 FY'24, and a 150% increase from Q3 FY'25's $1.42 million. Adjusted EBITDA turned positive in Q4 FY'25, compared to a $1.1 million loss in Q4 FY'24. Cash and equivalents stood at $6.85 million, with no debt. Organic growth was driven by Spatial Core's DoD contracts.
07-15 09:00
美股大行评级 | 潜在涨幅390.8%！HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级
多家机构首予Amrize买入评级，目标价53~62美元；HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级>>
06-25 08:39
WestPark Capital Reiterates Buy on Glimpse Group, Maintains $2.62 Price Target
WestPark Capital analyst Casey Ryan reiterates Glimpse Group (NASDAQ:VRAR) with a Buy and maintains $2.62 price target.
06-24 19:15
产业丨AI眼镜的新老对决：创业公司与科技巨头对垒
AI眼镜成为少数能够快速增长的蓝海市场 目前，市场上的AI眼镜产品主要分为以下四大类别：①仅具备音频与AI功能的眼镜；②集音频、拍照与AI功能于一体的智能眼镜...
06-19 20:30
美股大行评级 | 潜在涨幅112.77%！Craig-Hallum上调PLAYSTUDIOS目标价至3美元，评级升至"买入"
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1132955525493317632.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Craig-Hallum：上调PLAYSTUDIOS(MYPS)评级至"买入"，目标价从2美元升至3美元</p> <p>• Leerink Partners：上调Fulcrum Therapeutics(FULC)评级至"
05-24 08:40
美股大行评级 | 高盛上调微软目标价从480美元至550美元，Snowflake获多家机构上调目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1132593314765758464.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持IDEAYA Biosciences(IDYA)"超配"评级，目标价从63美元升至66美元</p> <p>• Needham：上调Inogen(INGN)评级至"买入"，目标价12美元</p> <p>• E
05-23 11:19
WestPark Capital Reiterates Buy on Glimpse Group, Maintains $2.62 Price Target
WestPark Capital analyst Casey Ryan reiterates Glimpse Group (NASDAQ:VRAR) with a Buy and maintains $2.62 price target.
05-23 00:10
12 Information Technology Stocks Moving In Thursday's After-Market Session
Gainers TSS (NASDAQ:TSSI) stock moved upwards by 33.5% to $11.84 during Thursd...
05-16 05:05
Glimpse Group shares are trading higher following Q3 financial results.
Glimpse Group shares are trading higher following Q3 financial results.
05-16 00:58
